In the fiercely competitive field of pharmaceutical raw materials and intermediates, Hangzhou Junchen Pharmaceutical Technology Co., Ltd. stands out with its profound technical foundation and innovative spirit. It focuses on the research and development, production, and sales of pharmaceutical raw materials and intermediates, safeguarding public health with high-quality products and services. ​

The raw materials of sulfamethoxazole and bromide sulfamethoxazole are the core products of the company. Neostigmine methyl sulfate is used for the treatment of surgical muscle relaxation antagonism and myasthenia gravis; Bromine neostigmine plays an important role in the treatment of neurological diseases. Two products rely on advanced technology and strict quality control, and are popular in domestic and foreign markets. ​

The company has established a comprehensive quality control system, strictly selects raw materials, adopts advanced equipment and standardized production processes, and undergoes multiple testing procedures to ensure that products meet international standards. In terms of research and development, establish a professional team, cooperate with universities and research institutions, accelerate the transformation of achievements, and continuously launch high-quality products. ​

Adhering to the concept of "customer first", the company has built a professional service team to provide customers with product consultation, technical guidance, and after-sales support. In the future, Junchen Pharmaceutical will adhere to the values of "integrity, innovation, excellence, and win-win", strengthen research and development and production, expand the market, and strive towards the goal of becoming a global leader in pharmaceutical raw materials and intermediates.